CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+12.33%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$15.6B
AUM Growth
+$1.15B
(+7.9%)
Cap. Flow
-$216M
Cap. Flow
% of AUM
-1.38%
Top 10 Holdings %
Top 10 Hldgs %
27.58%
Holding
755
New
44
Increased
354
Reduced
220
Closed
56
Top Buys
| 1 |
NVIDIA
NVDA
|
$80.1M |
| 2 |
Salesforce
CRM
|
$55.1M |
| 3 |
Micron Technology
MU
|
$53.8M |
| 4 |
Apple
AAPL
|
$50M |
| 5 |
Applied Materials
AMAT
|
$48.3M |
Top Sells
| 1 |
Merck
MRK
|
$73.5M |
| 2 |
ANSS
Ansys
ANSS
|
$53.4M |
| 3 |
Adobe
ADBE
|
$51.7M |
| 4 |
TJX Companies
TJX
|
$41.4M |
| 5 |
Thermo Fisher Scientific
TMO
|
$39.6M |
Sector Composition
| 1 | Technology | 31.73% |
| 2 | Healthcare | 28.37% |
| 3 | Financials | 8.73% |
| 4 | Consumer Discretionary | 8.29% |
| 5 | Industrials | 6.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCYC
151
Bicycle Therapeutics
BCYC
$496M
| $22.1M | 0.14% |
889,258
+20,000
| +2% | +$498K |
|
152
Halliburton
HAL
$18.8B
| $22M | 0.14% |
557,462
+147,034
| +36% | +$5.8M |
|
153
Mettler-Toledo International
MTD
$26.9B
| $21.8M | 0.14% |
16,385
-3,640
| -18% | -$4.85M |
|
154
Darling Ingredients
DAR
$5.07B
| $21.7M | 0.14% |
466,458
-266,281
| -36% | -$12.4M |
|
155
Zebra Technologies
ZBRA
$16B
| $21.6M | 0.14% |
71,731
+5,414
| +8% | +$1.63M |
|
156
CME Group
CME
$94.4B
| $21.4M | 0.14% |
99,608
-18,744
| -16% | -$4.04M |
|
157
Colgate-Palmolive
CL
$68.8B
| $21.3M | 0.14% |
236,860
+2,883
| +1% | +$260K |
|
158
Nuvalent
NUVL
$5.83B
| $21.3M | 0.14% |
284,009
+4,000
| +1% | +$300K |
|
159
Crown Holdings
CCK
$11B
| $21.2M | 0.14% |
267,282
-964
| -0.4% | -$76.4K |
|
160
Natera
NTRA
$23.1B
| $20.9M | 0.13% |
228,008
-13,979
| -6% | -$1.28M |
|
161
Stanley Black & Decker
SWK
$12.1B
| $20.8M | 0.13% |
212,003
+199,040
| +1,535% | +$19.5M |
|
162
TopBuild
BLD
$12.3B
| $20.7M | 0.13% |
47,047
-404
| -0.9% | -$178K |
|
163
Bio-Rad Laboratories Class A
BIO
$8B
| $20.6M | 0.13% |
59,658
-39,666
| -40% | -$13.7M |
|
164
Intercontinental Exchange
ICE
$99.8B
| $20.4M | 0.13% |
148,555
+15,692
| +12% | +$2.16M |
|
165
Quanta Services
PWR
$55.5B
| $20.4M | 0.13% |
78,448
+9,390
| +14% | +$2.44M |
|
166
Wabtec
WAB
$33B
| $20M | 0.13% |
137,549
-117
| -0.1% | -$17K |
|
167
Verisk Analytics
VRSK
$37.8B
| $19.7M | 0.13% |
83,718
+59,046
| +239% | +$13.9M |
|
168
MasTec
MTZ
$14B
| $19.7M | 0.13% |
211,341
+12,319
| +6% | +$1.15M |
|
169
Sarepta Therapeutics
SRPT
$1.96B
| $19.5M | 0.13% |
151,000
-31,445
| -17% | -$4.07M |
|
170
Veralto
VLTO
$26.2B
| $19.4M | 0.12% |
218,669
+64,487
| +42% | +$5.72M |
|
171
Dyne Therapeutics
DYN
$2.02B
| $19.2M | 0.12% |
675,624
-88,000
| -12% | -$2.5M |
|
172
Arvinas
ARVN
$575M
| $19.1M | 0.12% |
462,554
-25,001
| -5% | -$1.03M |
|
173
Broadridge
BR
$29.4B
| $19M | 0.12% |
92,757
+82,772
| +829% | +$17M |
|
174
GE Aerospace
GE
$296B
| $19M | 0.12% |
135,496
+5,307
| +4% | +$743K |
|
175
Revolution Medicines
RVMD
$7.57B
| $18.8M | 0.12% |
583,950
-23,000
| -4% | -$741K |
|